Dewey Stringer was diagnosed with kidney cancer on November 28, 2014. The next few months were a blur full of doctor appointments, chemotherapy and radiation treatments, losing weight, and where every day was worse than the previous one. He remembers hearing ‘particularly aggressive’, ‘tumors not responding to treatment’, and ‘months to live’. But Dewey wasn’t ready to die and spent his days researching cancer treatments. After learning about Dr. Jim Allison’s immunotherapy research at the University of Texas MD Anderson Cancer Center, he realized that was the treatment option that could save his life. And he was right.

In 2016, Dewey, appreciative of his life-saving treatment, decided to help cancer researchers in their quest to cure cancer, minimize side effects from treatment to improve patients’ quality of life, and provide rapid monitoring of tumor response to treatment.

Back to Board of Directors